STX209 (arbaclofen)

arbaclofen · Seaside Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for STX209 (arbaclofen), covering 2013-07-31 to 2013-07-31. Get the full timeline:

Most recent: Clinical Trial Update: Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders [Phase 3]